Articles tagged with Colorectal Cancer
Researchers developed a vaccine that stimulates colorectal cancer patients' immune systems to fight cancerous cells, with 70% of patients producing TNF-alpha and GM-CSF in response. The vaccine works by generating infection-fighting white blood cells called T cells, which destroy cancer cells.
A new set of quality indicators has been created to evaluate the quality of care received by patients undergoing colorectal cancer surgery. The guidelines cover aspects of surgical care, including pre-operative evaluation and post-operative management, to provide a valuable tool for improving patient outcomes.
Researchers identified 142 candidate indicators of quality care for colorectal cancer surgery, including surgical credentials, preoperative evaluation, and postoperative management. The expert panel rated 92 indicators as valid, suggesting these can be used to measure care quality and create improvement programs.
Studies found that colorectal cancer screening rates are increasing among Veterans Affairs patients, while younger veterans with other illnesses may not benefit from screening and may even be harmed. Screening methods include fecal occult blood testing and colonoscopy.
A new study by McGill University researchers has found that a diet low in folate may increase the risk of developing colorectal cancer. The study demonstrates a clear link between low dietary folate and the initiation of colorectal cancer in animal models, with 1 in 4 mice on a folate-deficient diet developing at least one tumour.
A new study found that only 33.3% of patients with locally advanced colorectal cancer received the recommended extensive surgery, which reduces local recurrence and improves survival rates. Aspirin takers with a specific genetic variant showed lower risk of developing colorectal adenomas.
A study published in Radiology found that virtual colonoscopy is an accurate screening method for colorectal cancer. The procedure was shown to be safer, faster, less costly, more convenient, and just as effective as optical colonoscopy in detecting polyps and cancers.
Researchers discovered a new target for future colon cancer treatments, a molecule involved in 85% of colon cancer cases. CTBP's accumulation in tumor cells with APC mutations leads to low retinoic acid production, causing improper cell development.
A new prediction model, MMRpro, assesses a person's probability of carrying a particular defect in mismatch repair genes, which predisposes families to colorectal cancer. The study found that MMRpro outperformed existing assessment tools in identifying mutation carriers and predicting colon cancer risk.
Two studies developed clinical models, PREMM1,2 and MMRpro, to predict the presence of mutations in MLH1 and MSH2 genes associated with Lynch syndrome. The models accurately estimated genetic risk for colorectal cancer, providing a timely tool for identifying and counseling families at risk.
Researchers at the University of Texas Medical Branch at Galveston discovered that curcumin blocks the activity of gastrointestinal hormone neurotensin, implicated in colorectal cancer development. Curcumin reduces IL-8 production, accelerating tumor growth and metastasis.
A new biomarker predicting survival in colorectal carcinomas has been discovered, with thymidylate synthase levels in the nucleus and cytoplasm identified as critical markers. The ratio of nuclear to cytoplasmic TS levels also predicts decreased survival, revealing a new potential biomarker for patients with worse prognosis.
A recent study published in the New England Journal of Medicine found that celecoxib, a commonly used painkiller, significantly reduced the incidence of potentially pre-malignant colorectal polyps by 36% in patients taking a daily dose. The study involved over 1,550 participants and showed a greater effect on advanced adenomas.
The APPROVe trial shows rofecoxib effective in reducing the recurrence of colorectal adenomas, a precursor to colon cancer. Patients taking rofecoxib had a lower recurrence rate (41% vs 55%) and reduced risk of advanced adenomas compared to those on placebo.
A study of over 9,000 Danish residents found that a specific variation in the CHEK2 gene triples a woman's risk of developing breast cancer in her lifetime. Women with this mutation are three times as likely to develop breast cancer as those without it.
A study of low-income housing residents found that those who watched more TV took fewer steps and were less likely to meet the recommended daily step count. The research used pedometers to measure physical activity and was conducted by researchers from Dana-Farber Cancer Institute.
A randomized controlled trial found that low-income Chinese-speaking patients were six times more likely to be screened for colorectal cancer when a clinic-based health educator provided culturally and linguistically appropriate counseling, educational materials, and screening test instructions. The intervention increased fecal occult ...
A large population-based study found that long-term smokers who never used NSAIDs had the highest risk of colon cancer. Smokers using NSAIDs still faced a 30% higher risk than nonsmokers. The study suggests NSAIDs may not counteract smoking's adverse effects on colorectal-cancer risk.
Researchers have developed a new test to detect rare genetic mutations in families at risk of passing on hereditary cancers like FAP. The innovative test allows for precise detection of mutations, enabling couples to make informed decisions about their pregnancies.
The study demonstrated a statistically significant benefit of FOLFIRI in patients with metastatic colorectal cancer, improving progression-free survival and overall survival. Adding bevacizumab to FOLFIRI also showed improved outcomes, with a higher percentage of patients alive after one year.
Long-term cancer survivors experience ongoing concerns about cancer recurrence and treatment side effects, affecting their mental health. Research found that these worries are linked to depression and anxiety, with varying levels of concern across different types of cancer.
Researchers used small interfering RNAs to block the spread of human colorectal cancer cells in laboratory mice, achieving a major reduction in liver cancer growth. The treatment also showed potential for increased cancer cell killing when combined with standard chemotherapeutic agents.
A study analyzed data from over 35,975 individuals who underwent colonoscopy without detecting colorectal neoplasia. The results showed a significant decrease in colorectal cancer incidence at 6 months (31%) and persisted for more than 10 years. A negative colonoscopy was associated with a lower risk of developing CRC.
A series of articles ranks preventive services by their cost-effectiveness and population health benefits, highlighting influenza vaccines and colorectal cancer screening as top priorities. The studies show that these services can save thousands of years of life and prevent deaths, with significant potential for improving overall healt...
Researchers recommend pre-screening to avoid worst liver damage caused by chemotherapy drugs. The study found that irinotecan was associated with steatohepatitis and oxaliplatin with sinusoidal dilation, which can lead to liver disease and failure.
Panitumumab significantly improves progression-free survival and disease control in patients with mCRC, with a median duration of response of 17 weeks. The treatment was well-tolerated, with few major adverse reactions.
Researchers found that MMP-9 is highly expressed by colon cancer cells and is key to initiating metastasis. By blocking the enzyme, colorectal cancer cells cannot metastasize to other tissue, suggesting a new target for preventing metastasis in colon cancer.
Current smokers and drinkers are diagnosed with colorectal cancer an average of 7.8 years younger than non-users, according to a new study. Flexible sigmoidoscopy may not detect proximal cancers as effectively as colonoscopy.
Researchers found a decreased risk of colorectal cancer for those taking high SSRI doses before diagnosis. The study's results provide interesting insights but highlight the need for further investigation and trial data.
Researchers found that individuals who smoke and drink developed colon cancer an average of 7.8 years earlier than non-users, with women showing a significant gap in cancer diagnosis age compared to men. The study suggests tailoring individualized screening programs based on tobacco and alcohol consumption.
Scientists discover that vitamin D can regulate an oncogenic protein called beta-catenin, which is involved in colon cancer development. A drug mimic of vitamin D could potentially prevent some cancers at early stages, but may not be effective for late-stage cancers.
A research group identified 679 genes differently expressed in responders to chemotherapy compared to non-responders. RT-PCR analysis validated the findings, confirming the differential expression of 22 genes. The study suggests integrating molecular networks could improve diagnosis and treatment of colorectal cancer.
Regular screening significantly reduces cancer deaths in families with hereditary Lynch syndrome, with a 70% decrease in mortality rates. Additionally, research finds that people with IBD-related CRC have similar prognoses as the general population, while a self-propelling colonoscope shows promise in efficient and safe detection.
The APC tumor suppressor has a novel function in regulating Wnt signaling in the nucleus. In this new study, researchers demonstrate that APC opposes beta-catenin activity directly at Wnt target genes. The findings suggest that full-length APC protein is necessary to repress c-Myc gene expression and prevent colon cancer progression.
Researchers found that hepatic arterial infusion (HAI) therapy extended survival and improved quality of life in patients with colorectal cancer that has spread to the liver. HAI therapy resulted in a median survival of 24 months, better response rates, and longer time to disease progression compared to systemic chemotherapy.
Researchers found a 12% reduction in hip fractures among women taking supplements, but only those who adhered to the full dosage saw benefits. Women over 50 should prioritize dietary sources of calcium and Vitamin D for bone health.
The study found a small but significant increase in hip bone density among women taking calcium combined with vitamin D. However, the supplements had no detectable effect on colorectal cancer incidence or spine fractures.
A study led by Dr. Richard Goldberg found that the chemotherapy regimen FOLFOX4 is effective in treating colorectal cancer regardless of age, including older patients over 70. The analysis of nearly 4,000 patients showed consistent benefits and side effects across all age groups.
A recent study found that low-income minority patients are underrepresented in colon cancer screenings, with only 7% receiving correct screenings. The study highlights the need for organizational interventions to support physicians in underserved areas and promote recommended screening practices.
Researchers tracked over 8 years and found no reduction in colorectal cancer cases with low-fat diet intervention. The study suggests that mid-to-late life dietary changes may not significantly impact colorectal cancer risk.
A study of nearly 49,000 postmenopausal women found a modest reduction in breast cancer incidence among those with high fat intake, but this benefit was not seen in those who reduced their fat intake. Women should focus on reducing saturated and trans fats, increasing vegetable consumption, and maintaining regular exercise for overall ...
Research on women with HIV found that those infected with both HIV and high-risk HPV were at greatest risk of developing cervical cancer precursors. A study on postmenopausal women found sex hormone levels to be not associated with breast cancer risk, while another study suggested that BRCA2 mutation carriers had a fourfold increased i...
Researchers propose a simple test that identifies more accurately individuals who might have colorectal cancer when used alongside traditional guaiac tests. This new approach could decrease the number of false positives in screening programs and reduce the need for colonoscopy, potentially leading to improved accuracy and reduced costs.
A large study of over 4000 participants found no association between statin use and reduced risk of colorectal cancer. The researchers noted that if statins strongly reduced the risk, any cholesterol-lowering drug would likely show some reduction in risk due to shared users.
A high-fiber diet from whole plant foods, but not isolated to cereal consumption, has been related to lower risks of chronic conditions such as heart disease and diabetes. However, a pooled analysis of 13 prospective cohort studies found no association between dietary fiber intake and reduced risk of colorectal cancer.
Researchers found L1 in large quantities exclusively in aggressive colon cancer cells, enabling them to invade and metastasize more effectively. The discovery may have important implications for diagnosing colon cancer and designing new therapies.
A new study found that increased physical activity is associated with a decreased risk of breast cancer in both black women and white women, regardless of disease stage or family history. Additionally, research on plant compound deguelin suggests it may interfere with tobacco-induced lung cancer development, while high plasma levels of...
Colorectal cancer affects millions across Europe, with a rapidly aging population highlighting the need for improved screening and prevention strategies. Researchers highlight irinotecan combined with 5-fluorouracil as an effective treatment regimen.
A combination treatment of Xeloda and oxaliplatin (XELOX) has been shown to reduce hospital visits by over 60% in patients with early colon cancer. This results in more time for patients to spend with family and return to work, improving their quality of life.
A recent study found that smoking significantly increases the risk of colorectal cancer in women, with the effect being more pronounced than in men. The researchers also discovered that colon cancer screening is beneficial for patients aged 75 and older, despite potential complications from endoscopy.
New studies show that young African Americans are at a much higher risk of developing pre-cancerous polyps compared to other racial groups. The American College of Gastroenterology recommends that African Americans begin colonoscopy screening at age 45, as opposed to the current recommended age of 50.
A study found that managed care programs failed to increase colorectal cancer screening rates, with only 26% of eligible patients receiving screening. The intervention program aimed to improve screening practices but had little impact after two years.
A randomized controlled trial found that a top-down approach to promoting colorectal cancer screening in physician organizations had no effect on increasing screening rates. However, the study identified key characteristics, such as integrated medical groups and regular physical exams, which could be targeted for future interventions.
A study found that CT colonography can detect cancer lesions and polyps with nearly the same sensitivity as colonoscopy, avoiding fatal perforations but potentially leading to more cancer-related deaths. The method's higher cost is offset by its non-invasive nature and appeal to patients.
Researchers discovered that TGFBR1*6A, a gene variant, significantly increases the risk of developing metastases in colorectal and head & neck cancers. In the presence of TGF-beta, cancer cells with this gene variant exhibit a selective growth advantage.
A recent study found that 50-94% of colorectal tumors have DNA gene changes, which could indicate a molecular defect. The study also found normal colon mucosa up to 10cm away from the tumor had similar gene changes.
A study found that long-term aspirin use lowers the risk of invasive colorectal cancer, especially in those taking high doses for more than 10 years. However, serious gastrointestinal bleeding risk increases with higher doses.
Long-term and regular aspirin use is associated with a significant reduction in colorectal cancer risk, with benefits observed at doses of 14 tablets per week or more. The study found that the risk of colorectal cancer decreased by up to 53% among women who took high-dose aspirin for over 10 years.
The largest study to date provides valuable insights into flexible sigmoidoscopy screening among 154,942 participants aged 55-74. Findings show that women are more likely to decline FSG than men, while non-acceptance increases with age in women. The rate of cancer detected was 2.9 per 1,000 individuals screened.
A new study found long-duration regular use of aspirin or NSAIDs may lower prostate cancer risk by 18%. Gene variants associated with melanoma risk were also identified in a Mediterranean population study, while another study found no link between gene mutations and response to bevacizumab